ArticleBMJ open diabetes research & care2014

Efficacy and safety of linagliptin in Hispanic/Latino patients with type 2 diabetes mellitus: a pooled analysis from six randomized placebo-controlled phase 3 trials.

Jaime A Davidson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.